Stay updated on ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC
Sign up to get notified when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.

Latest updates to the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new Revision: v3.4.2 banner was added, and the older Revision: v3.4.1 banner as well as the government funding notice banner were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operating status, with links to cc.nih.gov and opm.gov, and updated the revision to v3.4.1. The previous revision notice v3.4.0 was removed.SummaryDifference0.4%

- Check28 days agoChange DetectedUI and metadata updates were made: a Show glossary option is now available, and QC-related metadata fields were updated (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with a new Revision: v3.4.0, while the previous entries (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label changed from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe study locations are now presented under a single consolidated Locations section listing all participating states.SummaryDifference1%

- Check92 days agoChange DetectedRevision: v3.3.2 introduced; the previous revision tag v3.2.0 was removed.SummaryDifference0.0%

Stay in the know with updates to ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC
Enter your email address, and we'll notify you when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.